VDUP1 mediates nuclear export of HIF1α via CRM1-dependent pathway  by Shin, Daesung et al.
Available online at www.sciencedirect.com
1783 (2008) 838–848
www.elsevier.com/locate/bbamcrBiochimica et Biophysica ActaVDUP1 mediates nuclear export of HIF1α via CRM1-dependent pathway
Daesung Shin a,1, Jun-Ho Jeon a,1, Mira Jeong a, Hyun-Woo Suh a, Seyl Kim a,
Hyoung-Chin Kim b, Og-Sung Moon b, Yong-Sung Kim c, Jin Woong Chung a,
Suk Ran Yoon a, Woo-Ho Kim d, Inpyo Choi a,⁎
a Stem Cell Research Center, Korea Research Institute of Bioscience and Biotechnology, Yusong, Taejon 305-333, Republic of Korea
b Bio-Evaluation Center, Korea Research Institute of Bioscience and Biotechnology, Yusong, Taejon 305-333, Republic of Korea
c Genome Research Center, Korea Research Institute of Bioscience and Biotechnology, Yusong, Taejon 305-333, Republic of Korea
d Department of Pathology, Seoul National University, College of Medicine, Seoul 110-406, Republic of Korea
Received 14 August 2007; received in revised form 29 October 2007; accepted 29 October 2007
Available online 7 November 2007Abstract
Hypoxia-inducible factor 1α (HIF1α) is a critical transcriptional factor for inducing tumor metastasis, and stabilized under hypoxia but
degraded by von Hippel–Lindau protein (pVHL) under normoxia. For the maximal degradation of HIF1α, it must be exported to the cytoplasm
via an unidentified transporter. Here, we demonstrate that vitamin D3 up-regulated protein 1 (VDUP1) associates with the β-domain of pVHL and
enhances the interaction between pVHL and HIF1α to promote the nuclear export and degradation of HIF1α hypoxia-independently. Blocking of
VDUP1 translocation either by leptomycin B or by nuclear export signal mutation inhibited the nuclear export of pVHL/HIF1α and relieved the
destabilization of HIF1α. VDUP1 suppressed cell invasiveness and tumor metastasis, which were also recovered by blocking of nuclear export.
Taken together, these findings indicate that VDUP1 is a novel tumor suppressor which mediates the nuclear export of pVHL/HIF1α complex to
destabilize HIF1α.
© 2007 Elsevier B.V. All rights reserved.Keywords: HIF1α; pVHL; VDUP1; CRM1; Transport1. Introduction
Hypoxia-inducible factor 1 (HIF1) has a central role in
regulating oxygen homeostasis, tumor metastasis, and angio-
genesis [1,2]. Recent reports have shown that it is also involved
in more diverse physiological responses such as inflammation
and immune cell regulation [3,4].
HIF1 is a heterodimeric transcription factor that is composed
of HIF1α and HIF1β [5,6]. HIF1α is regulated at two inde-
pendent levels-transcriptional activation and protein stability.
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doi:10.1016/j.bbamcr.2007.10.012dependent on oxygen. In the presence of oxygen, HIF1α is
prolyl hydroxylated at specific residues (P402 and P564) in
oxygen-dependent domains by prolyl hydoxylases. Once hydro-
xylated, von Hippel–Lindau protein (pVHL) binds to HIF1α in a
complex with multi-component ubiquitin ligase (pVHL-Elongin
BC-Cul2-Rbx) to degrade HIF1α. Under hypoxic condition,
unhydroxylated HIF1α accumulates and translocates to the
nucleus, where it forms active complex with HIF1β to activate
the target genes. Upon reoxygenation, it is exported to the cyto-
plasm [7]. According to a recent model [8], prolyl hydroxylation
of HIF1α induces the binding of pVHL and ubiquitination of
HIF1α. Then, ubiquitinylated HIF1α is exported into the
cytoplasm to be degraded by 26S proteasome complex.
Shuttling of pVHL bound with HIF1α between the nucleus
and cytoplasm is prerequisite for the degradation of HIF1α in
the cytoplasm [8,9]. However, little is known about molecular
mechanism for pVHL/HIF1α translocation between the nucleus
and cytoplasm. In this study, we found that Vitamin D3 up-
Fig. 1. A. Kaplan–Meier survival curves for patients with gastric cancer. The
patients with VDUP1 positive cancers (dotted line) showed better prognosis
compared to those with VDUP1 negative cancers (solid line). The differences
between the two groups are statistically significant (pb0.001). B. Expression of
VDUP1 and HIF1α target genes in gastric cancer tissues was analyzed. Gastric
cancer tissues were prepared and analyzed by RT-PCR. N; normal tissue, and
T; tumor tissue.
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suppressor [10,11], decreased HIF1α stability by enhancing
nuclear export of pVHL/HIF1α complex and this process was
mediated by chromosome region maintenance 1 (CRM1) nu-
clear receptor-dependent pathway.
2. Materials and methods
2.1. Human tumor tissues and patient information
We used human gastric cancer tissue specimen preserved in the Department
of Pathology, Seoul National University Hospital. Primary gastric carcinoma in
these patients was diagnosed and treated at Seoul National University Hospital
between January 1, 1995 and June 30, 1995. The age, sex, tumor location, gross
type, tumor size, lymphatic invasion, and pTNM classification were evaluated
by reviewing the medical chart and pathologic report.
2.2. Cell lines and hypoxia conditions
293T, HeLa, H-1299, B16-F10 melanoma, and lung fibroblast cells were
maintained in DMEM supplemented with 10% fetal bovine serum. Lung
fibroblast cells were prepared from VDUP1 knockout mice and used in the
stages from passage number 3 to 7. For hypoxic condition, cells were incubated
at 1% O2 balanced with N2 in hypoxic chamber (Forma) for 4 h in HIF1α-
protein analyses and for 16 h in HIF1α-transactivation assay.
2.3. In vitro invasion assay
Cell invasiveness was assayed using BioCoat Matrigel invasion chamber
(BD Biosciences) according to the manufacturer’s instructions. In brief, HeLa
cells were transiently transfected with indicated plasmids using LipofectAMINE
Plus reagent (Invitrogen). After 24 h transfection, cells were detached using
trypsin-EDTA, resuspended in 750 μl of DMEM without serum, and plated at
3×104 number per upper chamber. DMEM containing 5% FBS was added to the
lower chamber and the plates were incubated at 37 °C. After 12 h, the plates
were moved into hypoxic condition and incubated more for 16 h. At completion,
cells were removed from the upper side of the membrane with a cotton swab, the
lower cells were fixed and stained with Toluidine Blue (Sigma), and then
mounted in mounting medium (DAKO). Stained cells in the lower side were
counted and data was expressed as the percent invasion of the mean of cells
invading relative to that of empty control cells.
2.4. In vivo metastasis assay
B16-F10 cellswere transfectedwith empty, VDUP1, orVDUP1-L294Avectors
using CytoPure-cmn reagent (Qbiogene). After 48 h later, cells (3×105 number in
0.1 ml of PBS) were injected i.v. into the lateral tail veins of 6-week-old C57BL6
female mice. Five mice were used for each sample. Animals were killed after
2 weeks injection and their lungs were removed for quantification of metastases.
2.5. Short interference knockdown of VDUP1
SiRNA of VDUP1 was designed and synthesized by Samchully Pharm.
(South Korea), with the following sequences. VDUP1 (sense); 5′-CCA UCC
AUG CUG ACU UUG ATT-3′, and VDUP1 (antisense); 5′-UCA AAG UCA
GCA UGG AUG GTT-3′. For negative control of siRNA, luciferase sequence
was used. GL2 (sense); 5′-CGU ACG CGG AAU ACU UCG ATT-3′ and GL2
(antisense); 5′-UCG AAG UAU UCC GCG UAC GTT-3′. 100 nM of annealed
duplex was transfected into the cells using LipofectAMINE Plus or 2000
(Invitrogen) according to the manufacturer's protocol.
2.6. Co-immunoprecipitaton assay
In order to evaluate the in vivo binding between pVHL and full- or partial-
sized VDUP1, 293T cells were transfected with HA-pVHL and GST-VDUP1 or-partial VDUP1 forms, as indicated. After 24 h of transfection, the lysate
supernatants were incubated for 1 h at room temperature with Glutathione
Sepharose 4B (Amersham Biosciences), washed three times in washing buffer
(lysis buffer containing 0.1% Triton X-100), then subjected to SDS-PAGE. In
order to assess binding between pVHL and HIF1α, the same cells were
transfected with Flag-pVHL, GST-HIF1α, and Flag-VDUP1 as indicated. After
24 h of transfection, the cells were incubated for 4 h with 10 μM MG-132
(Sigma) under hypoxic conditions, and then released into normoxic conditions
for 15 min. The cell lysates were immunoprecipitated via the same technique.
2.7. Immunofluorescence staining
HeLa cells were transfected with GFP-HIF1α, HA-VHL, and/or GST-
VDUP1 as indicated and were grown on coverslips for 24 h, and further
incubated under hypoxia or normoxia for 6 h. In some cases, cells were treated
with 1 ng/ml of leptomycin B (A.G. Scientific) for 2 h before fixation. Cells
Fig. 2. VDUP1 suppresses HIF1α expression. A. 293T cells were transiently transfected with VDUP1 and/or HIF1α cDNA. After 24 h transfection, cells were
incubated under hypoxia or normoxia for additional 4 h, and then lysates were immunoblotted for HIF1α and GFP. B. HeLa cells were transfected with increasing
amounts of VDUP1 cDNA and analyzed by western blotting for endogenous HIF1α and α-tubulin. C. Endogenous HIF1α expressed mostly in the nucleus (Mock).
When VDUP1 was ectopically expressed in HeLa cells, endogenous HIF1α was disappeared under both hypoxia and normoxia conditions (VDUP1). D. 293T cells
were cotransfected with different amounts of VDUP1 and/or HIF1α in the presence of HRE-LUC reporter plasmid. After 24 h transfection, cells were incubated under
hypoxia or normoxia for additional 16 h and then lysates were used for luciferase activity counting. The activity was normalized to β-galactosidase value. E. HeLa cells
were transfected with siRNA of VDUP1. After 24 h transfection, cells were incubated under hypoxia for additional 4 h and then lysates were analyzed. F. In VDUP1-
null lung fibroblast cells (−/−), HIF1α protein level was increased, but not the mRNA content. The expression of pVHL was not changed by VDUP1 in protein and
mRNA levels. G. HeLa cells were treated with the indicated amount of TNF-α for 6 h. Following the treatment, nuclear extracts (20 μg) were prepared and western
blotting was performed. Equal protein loading was confirmed with Histone H1 antibody. H. After HeLa cells were transfected with either control luciferase or VDUP1
siRNA, TNF-α (50 ng/ml) was added for 6 h. Following these treatments, nuclear extracts (20 μg) were prepared and western blotting was performed.
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15 min followed by 0.1% Triton X-100 for 5 min. And then cells were incubated
with primary antibody solution containing 1% BSA for 2 h, washed with PBS
for 30 min, and incubated with secondary, Cy3-labelled anti-rabbit and Cy5-
labelled anti-mouse IgG (Amersham Biosciences) for 1 h. After extensive
washing with PBS, coverslips were mounted with Vectashield (Vector
Laboratories) mounting medium for fluorescence with 4′, 6-diamidino-2-
phenylindole. Images were captured on a LSM510 confocal microscope (Carl
Zeiss) equipped with charge-coupled device. Total cellular HIF1α signal was
determined by multiplying the area of the cell by the averaged pixel intensity
using densitometry, and subcellular distribution of VDUP1 and pVHL were
obtained by the ratio of signal in the nucleus or cytoplasm to that of total cell
area.
3. Results
3.1. VDUP1 suppresses HIF1α stability
VDUP1 expression was evaluated in the 286 cases of primary
gastric tumor tissues. Of 286 cancer tissues, 21.0% (60 cases)
showed loss of expression in gastric tumor cells. The VDUP1
expression was strongly associated with the tumor stage, lymph
node metastasis and lymphatic invasion (Appendix A: Supple-
mentary Table S1). Lymph node metastasis was also signifi-
cantly associated with VDUP1 expression; only 10% showed
loss of expression in node-negative gastric cancers, but 27%
showed loss of expression in node-positive tumors. In addition,
the median survival duration in patients who had a tumor with
negative, and positive VDUP1 expression was 31 months and
71 months respectively (Fig. 1A, pb0.001). By multivariate
Cox regression model (Appendix A: Supplementary Table S2),
loss of VDUP1 expression was an independent prognostic factor
(p=0.021). Next, we compared the expression pattern of
VDUP1 and HIF1α target genes including VEGF, Glut-1, and
CAIx transcripts were analyzed in tumor tissues (Fig. 1B).When
VDUP1 expression was reduced in tumors, HIF1α target ex-
pression was elevated in most cases.
To know the possible direct interaction between VDUP1 and
HIF1α, the effects of VDUP1 on HIF1α expression were tested.
HIF1α was decreased dramatically by VDUP1 coexpression in
both hypoxia and normoxia conditions (Fig. 2A). VDUP1 also
reduces endogenous HIF1α in a dosage-dependent manner
(Fig. 2B). To confirm these observations, we monitored HIF1α
levels in HeLa cells transfected with VDUP1 by immunofluor-
escence staining. Endogenous HIF1α was disappeared comple-
tely in the presence of VDUP1 (Fig. 2C). To check whether
VDUP1 regulates HIF1α transcriptional activity, 293Tcells were
cotransfected with increasing amounts of VDUP1 and HIF1α in
the presence of luciferase reporter plasmid containing HIF1α-
response element (HRE-LUC). Luciferase activity induced by
HIF1α and/or hypoxia was clearly decreased with the increasing
amount of VDUP1 (Fig. 2D). It was observed that overexpression
of VDUP1 had no effects on cell death under hypoxic condition
(Appendix A: Supplementary Fig. S1). By transfecting siRNA of
VDUP1 into HeLa cells, we confirmed that endogenous VDUP1
is critical for the suppression of basal level of HIF1α (Fig. 2E). In
addition, HIF1α protein level in primary lung fibroblast of
VDUP1 knockout mice (−/−)[12] was comparedwith that of wild
type mice (+/+). HIF1α protein was significantly increased inVDUP1−/− cells, but no change in HIF1α mRNA (Fig. 2F).
Meanwhile, pVHL protein and mRNA levels were unaffected
by VDUP1 deficiency. However, VDUP1 protein expression
was not changed by overexpression of HIF1α (Appendix A:
Supplementary Fig. S2).
To understand physiological meaning and condition which
regulates VDUP1 and HIF1α, some stimuli were tested for
HIF1α regulation. TNF-α is known to increaseHIF1α expression
under normoxia condition [13,14]. When HIF1α was increased
by TNF-α treatment, VDUP1 was reduced simultaneously
(Fig. 2G). Next, VDUP expression was reduced by transfecting
siRNA of VDUP1 into HeLa cells. TNF-α induced HIF expres-
sionmuchmore in combinationwith siRNAofVDUP1 (Fig. 2H),
further confirming that endogenous level of VDUP1 is critical for
the regulation of HIF1α expression. Overall, these results indicate
that VDUP1 decreases HIF1α protein stability.
3.2. VDUP1 enhances the association between pVHL and
HIF1α
Since the degradation of HIF1α is predominantly processed
via pVHL-mediated proteasomal degradation in cytoplasm [17],
we next tested whether VDUP1 interacts with pVHL. 293T cells
were cotransfectedwith pVHL andVDUP1, and analyzed by co-
immunoprecipitation. This assay showed that both of them could
interact physically in vivo (Fig. 3A). Endogenous pVHL also
interacted with endogenous VDUP1 (Fig. 3B). To map pVHL
domains involved in this interaction, we tested the binding
of HA-tagged deletion constructs of pVHL with full-length
VDUP1. Result showed that VDUP1 bound to the residues 93–
123 amino acids of β-domain of pVHL (Fig. 3C). This region is
known as a substrate-binding site and required for nuclear export
[18]. VDUP1 region spanning 148–235 amino acids was
required for the interaction with pVHL (Fig. 3D). To evaluate
the biochemical consequence of the physical interaction of
VDUP1 and pVHL on HIF1α, the dosage effects of VDUP1 on
the interaction between pVHL and HIF1α were first tested.
Using the co-immunoprecipitation assay with exogenous pVHL,
HIF1α, and VDUP1, we knew that, the greater the amount of
VDUP1 was coexpressed in the presence of constant pVHL, the
more pVHL was immunoprecipitated by HIF1α pull-down
(Fig. 3E).When the interaction between both endogenous pVHL
and HIF1α was monitored in the VDUP1 wild type or knockout
lung fibroblast cells, the binding became stronger in the presence
of wild type VDUP1 (Fig. 3F; +/+) than in the absence of
VDUP1 (−/−). These results suggested that VDUP1 could
function as a regulator of pVHL/HIF1α complex by strengthen-
ing the association of pVHL with HIF1α. Because VDUP1
increased the association of HIF1α/pVHL complex and HIF1α
degradation, the effect of VDUP1 on mutant HIF1α P402A/
P564Awhich can not associate with pVHL was tested (Fig. 3G).
VDUP1 did not induce mutant HIF1α degradation due to
blocking the complex of pVHL/HIF1α, indicating that the effect
of VDUP1 on HIF1α is dependent on association of this com-
plex. VDUP1 has been known as a binding partner of TRX and
inhibits TRX activity by interacting with two cysteine residues
of TRX active site [15,16]. VDUP1 decreased HIF1α stability
842 D. Shin et al. / Biochimica et Biophysica Acta 1783 (2008) 838–848regardless of wild type TRX or mutation-form (Appendix A:
Supplementary Fig. S3), indicating that VDUP1 regulates
HIF1α through non-TRX-dependent pathway. In addition, the
effects of TRX on the interaction between VDUP1 and pVHL
were tested (Appendix A: Supplementary Fig. S4). Co-
transfection of TRX had no effects on the interaction between
two molecules. Also, H2O2 treatment did not affect the inter-
action significantly (Appendix A: Supplementary Fig. S4B).These results demonstrate that this interaction is independent of
TRX or cellular redox status.
3.3. VDUP1 is responsible for nuclear export of pVHL/HIF1α
To understand molecular mechanism of VDUP1-mediated
HIF1α protein degradation, we examined the nucleocytoplasmic
shuttling of HIF1α and pVHL, which is prerequisite for the
843D. Shin et al. / Biochimica et Biophysica Acta 1783 (2008) 838–848degradation ofHIF1α in the cytoplasm [8,9,19], in the presence of
VDUP1. We used a GFP-HIF1α fusion protein which increased
HIF1α half-life and was used for observing the intracellular
localization of HIF1α [20]. VDUP1 is expressed dominantly in
the nucleus (Appendix A: Supplementary Fig. S5). In the pres-
ence of either HIF1α or pVHL, VDUP1 still localized to the
nucleus with some cytoplasmic signal (Fig. 4A; row 1 and 2). The
35–39% in hypoxia and 45–69% in normoxia ofVDUP1 proteins
were exported into the cytoplasm (Fig. 4C). Interestingly, when
both HIF1α and pVHL were coexpressed simultaneously in the
presence of VDUP1, VDUP1 was exported dramatically into the
cytoplasm (Fig. 4A; row 4), with the over 90% of cytoplasmic
fractions (Fig. 4C). In this condition, the nuclear fractions of
pVHL were also decreased into one-third of the quantities com-
pared to that of the pVHL sole expression (Fig. 4D), and HIF1α
was reduced more in the nucleus (Fig. 4A; row 4 and B). If
VDUP1/pVHL are responsible for degradation of HIF1α in the
cytoplasmwithout nuclear export ofHIF1α, the amount ofHIF1α
in the nucleus would be constant when VDUP1/pVHL were
transfected. Together, it shows that VDUP1 augments the nuclear
export of pVHL bound with HIF1α.
The pVHL protein is exported by exon-2 encoded β-domain
(residues from 114 to 154), which does not contain any functional
NES [18]. Interestingly, this region is overlappedwith the binding
site with VDUP1 (Fig. 3C). A newly found tumor suppressor,
VDUP1 is also imported by importin-α pathway [21] and con-
tains a putative CRM1-mediated leucine-rich NES from 290
residue to 296 (LDLPLVI) (Fig. 5A) which was identified by
prediction using NES predictor with the highest score at leucine
294 residue [22]. To determine whether the NES in VDUP1 is
important for nuclear export, we mutated the residue 294 leucine
of VDUP1 into alanine (VDUP1-L294A) and found that the
export was diminished significantly by this change (Fig. 5A row
2), with 4–6 fold and 3–5 fold increases of nuclear fractions for
VDUP1 and pVHL (Fig. 5C and D). Using leptomycin B (LMB),
which blocks specifically CRM1-dependent nuclear export and is
used extensively to probe this process [23], we knew that the
export of VDUP1 to cytoplasm is mediated by CRM1 pathway
with the increases of nuclear fractions of both VDUP1 and pVHL
similar to the results of VDUP1-L294A mutation (Fig. 5A;
row 3).Whenwe analyzed the total HIF1α intensity in overall cell
area for quantitative purposes, HIF1α amount was partiallyFig. 3. VDUP1 interacts with pVHL/HIF1α complex. A. 293T cells were either tran
immunoprecipitated after 24 h transfection, pVHL was coprecipitated with GST-VDU
control IgG or anti-VDUP1 monoclonal antibody and detected pVHL by western b
whole cell lysates, IP; immunoprecipitation. C. 293T cells were either transfected w
clones harboring 93–123 residues of pVHL were coprecipitated with VDUP1 (lane 1
expression vectors, and asterisk (⁎) is the interaction site. D. The same cells were trans
by anti-GST antibody. pVHL was coprecipitated with the vectors containing 148–2
different amount of VDUP1, GST-HIF1α, and pVHL as denoted. After 24 h transfect
and then released into normoxia for 10 min. Lysates were immunoprecipitated with
Histograms to the below show the relative precipitated pVHL amounts. F. The intera
and VDUP1-null (−/−) lung fibroblast cells. Each cell was incubated under hypoxia
normoxia for 4 h and 10 min. Lysates were immunoprecipitated with anti-pVHL antib
the wild type (+/+) cells, not in VDUP1-null (−/−). G. 293T cells were co-transfected
VDUP1. After 24 h transfection, cells were prepared and analyzed by western blott
resistant to VDUP1-mediated degradation.recovered in the presence of VDUP1-L294A orVDUP1-WTwith
LMB (Fig. 5B). As a matter of fact, VDUP1 interacted with
CRM1 but not with L294A mutation form, regardless of the
overexpression of pVHL and HIF1α (Fig. 6A). Additionally, the
mutation had no effect on the binding between pVHL and
VDUP1 (Fig. 6B), which could be already predicted by the
evidence that the binding region of VDUP1 with pVHL is
spanning 148–235 amino acids (Fig. 3D). Overall, these data
show that VDUP1 mediates the nuclear export of HIF1α via
CRM1 receptor pathway.
3.4. VDUP1 inhibits HIF1α functions
Next, we investigated whether the nuclear export event
affects the destabilization and function of HIF1α. The VDUP1-
L294A relieved the destabilization of HIF1α by VDUP1 in both
human cervical cancer cell line (HeLa) and lung cancer cell (H-
1299) (Fig. 7A). HIF1α highly increases the cells' invasiveness
under both nonhypoxic and hypoxic conditions [24]. Compared
with empty vector (Vec), transfection of cells with wild type
VDUP1 (WT) resulted in a significant decrease in invasiveness
in HeLa cells. However, when VDUP1-L294A was expressed,
the invasiveness was recovered (Fig. 7B). To test whether
L294A-export defective mutant would block the suppression of
tumor metastasis by VDUP1, we transfected B16-F10 mela-
noma cells with empty, VDUP1, or VDUP1-L294A expression
vector. Growth and morphology of transfectants were not
grossly changed. The transfectants (3×105) were injected into
the lateral tail vein of C57BL/6 mice and after 2 weeks, the
number of lung metastases per animal was counted (Fig. 7C).
Compared to the average number of metastases in empty vector-
injected mice (198/mouse), VDUP1 mice suppressed melanoma
metastases dramatically (69/mouse). VDUP1-L294A injected
mice developed 102 per mouse with partial recovered metas-
tases. These results confirm that VDUP1 suppresses HIF1α
function by modulating the nuclear export via CRM1-dependent
pathway.
4. Discussion
In this paper, we show that VDUP1 exists in a pVHL/HIF1α
complex for the negative regulation of HIF1α and propose asfected with pVHL and GST or GST-VDUP1. When GST or GST-VDUP1 was
P1 (lane 4), not with GST (lane 2). B. HeLa cell lysates were precipitated with
lotting analysis. Endogenous pVHL interacts with endogenous VDUP1. WCL;
ith GST-VDUP1 and full-length pVHL or a series of pVHL partial forms. The
, 2, and 4). Diagram represents the pVHL domains and cover-regions of partial
fected with pVHL and GST-VDUP1 deletion constructs and immunoprecipitated
35 residues of VDUP1 (lane 2, 3, 5 and 6). E. 293T cells were transfected with
ion, cells were incubated under hypoxia with 10 μMMG-132 for additional 4 h,
anti-GST antibody and analyzed by western blotting for pVHL and VDUP1.
ction between endogenous HIF1α and pVHL was monitored in wild type (+/+)
with 10 μM MG-132 for 4 h / additional for 10 min under normoxia or under
ody and analyzed by western blotting for HIF1α. HIF1α interacted with pVHL in
with GST-HIF1α or proline-mutated HIF1α(P402A,P564A) in the presence of
ing with co-transfected GFP as an internal control. Proline-mutated HIF1α was
Fig. 4. VDUP1 exports pVHL/HIF1α from the nucleus. A. HeLa cells were transfected with HIF1α, pVHL, and VDUP1 as denoted and analyzed by confocal
microscopy for each protein. When expressed with pVHL or HIF1α, the major portion of VDUP1 was still enriched in nucleus (row 1 and 2). However, VDUP1 was
translocated into cytoplasm dramatically in the coexpression with pVHL and HIF1α (row 4). The cytoplasmic localized pVHL was also increased and HIF1α was
more degraded in this condition. These phenomena were not dependent on oxygen tension. B. For the quantitative purposes, the intensity of HIF1α in overall cell area
was measured and the value in the sole expression of VDUP1 was set to 100%. Subcellular distributions of HIF1α (B), VDUP1 (C), and pVHL (D) between nucleus
and cytoplasm were depicted by histograms. Black bars are nuclear portion and white bars are cytoplasmic.
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complex. In view of this finding and the known functions of
VDUP1, as a tumor and metastasis suppressor [25–27], it isreasonable to suggest that induction of VDUP1 and its function
as a nuclear export mediator is one of key points for the degra-
dation of HIF1α in the cellular stress conditions.
Fig. 5. CRM1 mediates the nuclear export of pVHL/HIF1α/VDUP1 ternary complex. A. When VDUP1-L294A was expressed with pVHL and GFP-HIF1α, the
nuclear exports of VDUP1 and pVHL were partially decreased (VDUP1-L294A; Leucine at 294 residue has been changed into alanine). The treatment of leptomycin
B, a specific inhibitor of nuclear export receptor CRM1, also diminished the export phenotype (VDUP1-WT+LMB). Relative HIF1α signals (B) were represented by
the averaged intensity measured on confocal images. Subcellular distribution of VDUP1 (C) and pVHL (D) was depicted by the percentages of nuclear or cytoplasmic
portion. Black bar is nuclear and white bar is cytoplasmic percentage.
845D. Shin et al. / Biochimica et Biophysica Acta 1783 (2008) 838–848VDUP1 functions as tumor- and metastasis-suppressors
(Fig. 7) by increasing pVHL/HIF1α association (Fig. 3) to accel-
erate nuclear export of pVHL/HIF1α via CRM1-dependent
pathway (Figs. 5,6) and then increasing HIF1α degradation in
the cytoplasm. In this process, VDUP1 becomes to associate with
pVHL/HIF1α complex and then associates with CRM1 exportin.
HIF1α, exported by pVHL/HIF1α/VDUP1/CRM1 quaternary
complex, become liable to be degraded by 26S proteasome. As
previously reported [8], it seems that poly-ubiquitination ofHIF1α
by pVHL/VDUP1 complex is required for the nuclear export of
the ternary complex via CRM1 pathway. Physiologically, TNF-α
which decreases VDUP1 expression redox-dependently increases
HIF1α stability. Hypoxia or nonhypoxic cellular stress stabilizesHIF1α, which activates HRE transcription. Later, the same stress
induces VDUP1 enriched in the nucleus.
For tumor suppressor proteins, their dynamic intracellular
translocation is considered as a key mechanism for the regulation
of their own protein stability and function [28,29]. Most of them
are imported into the nucleus by importin-α/β, BARD1, or B56α
receptor pathway, whereas nuclear export is mostly mediated by
CRM1 receptor [30,31]. In addition, it was reported that HIF1α
nuclear export was not mediated by CRM1 based on inhibitor
sensitivity [32]. Prostagladin E2, butylate, and TNF-α were
reported to modulate HIF1α translocation by unknown mechan-
isms [13,33]. Recent study showed that acidosis can sequester
pVHL into necleous to inhibit HIF1α degradation [34]. Many
Fig. 6. VDUP1 interacts with CRM1. A. 293T cells were either transfected with
GST (lane 1 and 4), GST-VDUP1 (lane 2 and 5), or GST-VDUP1-L294A (lane 3
and 6) in the absence or presence of over-expressed pVHL and HIF1α. After
24 h transfection, the lysates were precipitated by glutathione sepharose 4B and
detected with anti-CRM1 and anti-pVHL antibodies. B. The same cells were
either transfected with GST (lane 1 and 4), GST-VDUP1 (land 2 and 5), or GST-
VDUP1-L294A (lane 3 and 6) in the absence or presence of overexpressed
pVHL. After 24 h transfection, the lysates were precipitated by anti-HA agarose
and detected with anti-GST antibody.
846 D. Shin et al. / Biochimica et Biophysica Acta 1783 (2008) 838–848factors such as p300, Ref-1, andKRABare known to interact with
HIF1α to modulate the transcriptional activity of HIF1α [35,36],
but none of them are involved in nuclear export of HIF1α. In this
study, we demonstrated that HIF1α export is CRM1-dependent in
the presence of VDUP1, which previous reports did not test,
based on physical association of VDUP1 and CRM1, mutant
VDUP1L294A, and inhibitor sensitivity. Taken from these data,
HIF1α export seems to be dependent on cell types and conditions,
perhaps involving several mechanisms and molecules.
pVHL has diverse molecular partners for various functions,
including HIF1α, Elongin C, Elongin B, TBP-1, HSP70/TriC,
FIH-1, VHLaK, VDU-1, Rpb7, Rpb1, Sp1, aPKCλ, α-tubulin,
and Fibronectin [37]. Hence mutations occurred through pVHL
gene result in complex phenotypic changes. Until now, 279
mutations are reported in the VHL mutation Database (http://
www.vhl.org). Here, we describe another novel interaction
between the β domain of pVHL and VDUP1. This association
mediates the nuclear export of HIF1α and eventually accel-
erates the degradation of it.Fig. 7. VDUP1 regulates tumor metastasis via nuclear transport. A. HeLa and H-129
vector (Vec). After 24 h tranfection, cells were incubated under hypoxia or normo
α-tubulin. Polygonal graph to the below show the change of HIF1α proteins relative to
The cells overexpressing wild type VDUP1 or VDUP1-L294A were assayed for inva
membrane were visualized by a Toluidine blue stain. Representative fields are shown fro
standard deviation of four independent experiments. C. Melanoma metastasis is sup
melanoma cells were transfected as indicated and injected into the lateral tail veins of C57
represented as the average number±standard deviation of five independent animals.Regulation of HIF1α level is a key event for controlling the
expression of a myriad of genes involved in hypoxic response,
glucose metabolism, angiogenesis, and oxygen transport. In the
cells, HIF1α is regulated at various pathways including tran-
scription, translation, post-translation, protein interaction, and
degradation. Besides hypoxia/hypoxia mimetics, there are about
20 known positive or negative regulators for HIF1α, but none of
them is involved in nuclear export of HIF1α directly.
It has been reported that HIF1α location/degradation is de-
pendent on cell types [38]. In transformed HeG2 cells, HIF1α
degradation occurred mainly in the cytoplasm, whereas it occurs
with equal efficiency in the nucleus and the cytoplasm of primary
endothelial cells. Also, HIF1α/pVHL location is dependent on
cell conditions and stimuli. VHL translocation is determined by
cell density or various stimuli including hypoxia, PGE2, and
TNF-α [39]. It will be a reasonable assumption that a role of
VDUP1 in HIF1α degradation and translocation is also cell-type
specific and cell-condition specific. In this study, we showed
that VDUP1 have a role in HIF-1α degradation when cells were
treated with TNF-α, but not in the case of SAHA (data not
shown).
Overall, VDUP1 is a novel tumor suppressor which is
responsible for HIF1α nuclear export. VDUP1 as a bridge for
pVHL/HIF1α complex linking to CRM1 can be an important
target for the therapy of malignant tumor progression.
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